Monroe backs Altaris Capital's buyout of Kindeva

Monroe Capital has provided funding to back Altaris Capital Partners' acquisition of Kindeva Drug Delivery LP.

4 May 2020•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.